<DOC>
	<DOC>NCT00160511</DOC>
	<brief_summary>16 week trial assessing the efficacy, safety, and tolerability of levetiracetam compared with placebo in the treatment of postherpetic neuralgia.</brief_summary>
	<brief_title>A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia, Postherpetic</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>male or female outpatient greater than or equal to 18 years of age. suffering presently from neuralgia, which has been present for at least 3 months since healing of acute herpes zoster skin rash. PHN pain at entry into the study must meet the following criteria: a VAS of at least 40 mm at visit 2 (to assess pain intensity during the past week) and with an average daily score of at least 4 on the PIS during the baseline period as evaluated on a minimum of 4 days. an estimated creatinine clearance of at least 50 ml/min. receiving professional psychological support (such as cognitive behavioral therapy) currently or within 2 weeks prior to visit 1 specifically for coping with PHN. previous neurolytic or neurosurgical therapy for PHN, at any time in the subject's history or treatment with TENS (transelectroneuro stimulation) currently or within the past 2 weeks. known coexistent source of pain or painful peripheral neuropathy. known significant neurological disorder other than the study disease or a condition which can mimic stroke with distal neurological deficit (amyotrophy, radiculopathy, history of TIAs, multiple sclerosis, or any amputations). conditions known to be associated with immunosuppressive states. clinically significant major depression defined as a Beck Depression Inventory Score &gt; 21 at selection including those with a history of Bipolar Disorder.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Postherpetic Neuralgia (PHN)</keyword>
	<keyword>Levetiracetam</keyword>
	<keyword>Keppra</keyword>
	<keyword>Nerve Pain</keyword>
</DOC>